In vitro activities of linezolid, meropenem, and quinupristin-dalfopristin against group C and G streptococci, including vancomycin-tolerant isolates

被引:8
|
作者
Zaoutis, T
Moore, LS
Furness, K
Klein, JD
机构
[1] Alfred I duPont Hosp Children, Div Pediat Infect Dis, Wilmington, DE 19899 USA
[2] Christiana Hosp, Christiana Care Hlth Syst, Infect Dis Lab, Newark, DE USA
关键词
D O I
10.1128/AAC.45.7.1952-1954.2001
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The in vitro activities of meropenem, linezolid, quinupristin dalfopristin, vancomycin, and penicillin against 130 clinical isolates of group C and G streptococci, including vancomycin-tolerant isolates, were evaluated. Meropenem, linezolid, quinupristin-dalfopristin, vancomycin, and penicillin MICs at which 90% of the isolates were inhibited were 0.06, 2.0, 0.25, 0.5, and less than or equal to0.016 mug/ml, respectively. Meropenem, linezolid, quinupristin-dalfopristin, and penicillin were active against group C and G streptococci, including vancomycin-resistant strains.
引用
收藏
页码:1952 / 1954
页数:3
相关论文
共 44 条
  • [31] Antimicrobial activity of mupirocin, daptomycin, linezolid, quinupristin/dalfopristin and tigecycline against vancomycin-resistant enterococci (VRE) from clinical isolates in Korea (1998 and 2005)
    Lee, Do Kyung
    Kim, Yuna
    Park, Kun Sup
    Yang, Jae Wook
    Kim, Kyungjae
    Ha, Nam Joo
    JOURNAL OF BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2007, 40 (06): : 881 - 887
  • [32] Comparative activities of clinafloxacin, grepafloxacin, levofloxacin, moxifloxacin, ofloxacin, sparfloxacin, and trovafloxacin and nonquinolones linozelid, quinupristin-dalfopristin, gentamicin, and vancomycin against clinical isolates of ciprofloxacin-resistant and -susceptible Staphylococcus aureus strains
    Jones, ME
    Visser, MR
    Klootwijk, M
    Heisig, P
    Verhoef, J
    Schmitz, FJ
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (02) : 421 - 423
  • [33] Nationwide German multicenter study on the prevalence of antibiotic resistance in streptococcal blood isolates from neutropenic patients and comparative in vitro activities of quinupristin-dalfopristin and eight ether antimicrobials
    Reinert, RR
    von Eiff, C
    Kresken, M
    Brauers, J
    Hafner, D
    Al-Lahham, A
    Schorn, H
    Lütticken, R
    Peters, G
    JOURNAL OF CLINICAL MICROBIOLOGY, 2001, 39 (05) : 1928 - 1931
  • [34] In vitro activities of linezolid against important gram-positive bacterial pathogens including vancomycin-resistant enterococci
    Noskin, GA
    Siddiqui, F
    Stosor, V
    Hacek, D
    Peterson, LR
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (08) : 2059 - 2062
  • [35] Distribution of tetracycline resistance genes teit(M), tet(O), tet(L) and tet(K) in blood isolates of viridans group streptococci harbouring erm(B) and mef(A) genes.: Susceptibility to quinupristin/dalfopristin and linezolid
    Rodriguez-Avial, I
    Rodriguez-Avial, C
    Culebras, E
    Picazo, JJ
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2003, 21 (06) : 536 - 541
  • [37] In vitro activities of ceftobiprole, dalbavancin, daptomycin, linezolid, and tigecycline against methicillin-resistant Staphylococcus aureus blood isolates: stratified analysis by vancomycin MIC
    Chong, Yong Pil
    Park, Su-Jin
    Kim, Hee Sueng
    Kim, Eun Sil
    Kim, Mi-Na
    Kim, Sung-Han
    Lee, Sang-Oh
    Choi, Sang-Ho
    Jeong, Jin-Yong
    Woo, Jun Hee
    Kim, Yang Soo
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2012, 73 (03) : 264 - 266
  • [38] In vitro activities of fluoroquinolones against antibiotic-resistant blood culture isolates of viridans group streptococci from across Canada
    de Azavedo, JCS
    Trpeski, L
    Pong-Porter, S
    Matsumura, S
    Low, DE
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (09) : 2299 - 2301
  • [39] Comparative in vitro activities of daptomycin, vancomycin, teicoplanin and linezolid against resistant Gram-positive bacterial isolates from two large centres in western India
    Biswas, Sanjay
    Watwani, Jaya
    Vadwai, Viral
    Shetty, Anjali
    Kelkar, Rohini
    Rodrigues, Camilla
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2012, 40 (06) : 567 - 569
  • [40] Comparative in-vitro activities of RP59500 (quinupristin/dalfopristin), CL 329,998, CL 331,002, trovafloxacin, clinafloxacin, teicoplanin and vancomycin against Gram-positive bacteria
    Shonekan, D
    Handwerger, S
    Mildvan, D
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1997, 39 (03) : 405 - 409